Mononuclear Therapeutics (MonoTx ®) Limited collects, processes, tests and banks human umbilical cord blood (UCB) and
components for research and to treat disease. The MonoTx ® cord blood bank complies with international standards for treating hematologic disorders. MonoTx ® cord blood bank is AABB accredited and FDA registered. MonoTx ® is also a member of
World Marrow Donation Association (WMDA) for release of cord blood cells for hematopoietic diseases treatment.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Hong Kong Science Park, Unit 206,16w,hong Kong
- Industry
- Biotechnology
- Website
- http://www.monotx.com
- Keywords
- Xellera Therapeutics.
- HQ
- Hong Kong, New Territories
Mononuclear Therapeutics Limited Questions
Mononuclear Therapeutics Limited's website is http://www.monotx.com
Mononuclear Therapeutics Limited's LinkedIn profile is https://hk.linkedin.com/company/monotx
Mononuclear Therapeutics Limited has
5 employees.
View email and phone details for 5
employees at Mononuclear Therapeutics Limited.
Mononuclear Therapeutics Limited's industry is
Biotechnology
Mononuclear Therapeutics Limited's top competitors are
Medera Inc.,
Codex Genetics,
Sinomab Bioscience Limited,
Prenetics,
Hong Kong Regen Medtech Limited,
Act Genomics,
Hkstp - Hong Kong Science And Technology Parks Corporation,
Hong Kong Society For Quality (Hksq),
Xellera Therapeutics,
Rare Power.
Mononuclear Therapeutics Limited's categories are Biotechnology
Mononuclear Therapeutics Limited's founding year is 2016
